| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0aeefb5f6845db0336d7646f17c306c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8979f668f006ff308baf5a67e4889779
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb567a68172e9763ed11b891531bd34d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7366be80b59f388acea1e41e2441b8e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c379f23f6256c362ea1c7f18e32c6e71 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate |
2007-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace130fbb85f9b8fd4a8c35cc0d3e3d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bc0a1d564289457c654c3657ba58e67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f8f8a08be41d472005ada89358a1ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b531de1a504af2c1db0af00f3eda058e |
| publicationDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2008127347-A1 |
| titleOfInvention |
Pro115 antibody compositions and methods of use |
| abstract |
The invention provides isolated anti-Pro115 antibodies that bind to Pro115. The invention also encompasses compositions comprising an anti-Pro115 antibody and a carrier. These compositions can be provided in an article of manufacture or a kit. Another aspect of the invention is an isolated nucleic acid encoding an anti-Pro115 antibody, as well as an expression vector comprising the isolated nucleic acid. Also provided are cells that produce the anti-Pro115 antibodies. The invention encompasses a method of producing the anti-Pro115 antibodies. Other aspects of the invention are a method of killing an Pro115-expressing cancer cell, comprising contacting the cancer cell with an anti-Pro 115 antibody and a method of alleviating or treating an Pro 115 -expressing cancer in a mammal, comprising administering a therapeutically effective amount of the anti- Pro115 antibody to the mammal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10941213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019147831-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112533951-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3998280-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021163076-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603413-B2 |
| priorityDate |
2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |